Newsroom | 2258 results

Sorted by: Latest

Start-Up
-

Endpoints News Announces the 2025 Winners of the Endpoints 11 Awards, Highlighting Biotech’s Most Promising Startups

LAWRENCE, Kan.--(BUSINESS WIRE)--Endpoints News Announces the 2025 Winners of the Endpoints 11 Awards, Highlighting Biotech’s Most Promising Startups...
-

Panaxium Research Signs Exclusive IP Agreement with University of Washington to Advance Dynamic Neurostimulation Stroke Recovery Therapy

TORONTO & SEATTLE--(BUSINESS WIRE)--Panaxium Research Signs Exclusive IP Agreement with University of Washington to Advance Dynamic Neurostimulation Stroke Recovery Therapy...
-

Wells Fargo Innovation Incubator Selects Three Startups for Resiliency-Focused Cohort

DENVER--(BUSINESS WIRE)--The Wells Fargo Innovation Incubator (IN2), a $55 million energy technology program funded by Wells Fargo & Company and coadministered by NREL, a U.S. Department of Energy national laboratory, today announced the selection of three startups for its next cohort in the Emerging Tech track. This cohort focuses on enhancing resiliency in the built environment through innovative technologies that strengthen building operations, heating and cooling systems, and grid relia...
-

T.Rx Capital Launches $77.5M Fund I to Invest in Bold Startups at the Intersection of Technology and Biology

BOSTON--(BUSINESS WIRE)--T.Rx Capital Launches $77.5M Fund I to Invest in Bold Startups at the Intersection of Technology and Biology...
-

Patero Selected for Fall 2025 Cohort of Khasm Labs’ 5G Open Innovation Lab

COLLEGE PARK, Md.--(BUSINESS WIRE)--Patero, a pioneer in post-quantum cryptography, today announced its selection to the Fall 2025 cohort of Khasm Labs’ 5G Open Innovation Lab. This highly competitive program accelerates collaboration between startups, enterprises, and communications providers. Khasm Labs is shaping the future at the intersection of AI, edge computing, robotics, and secure infrastructure. From quantum-safe encryption and robotic skills platforms to ultra-fast inference and next...
-

Intelligent Legal Solutions Secures Strategic Investment from The LegalTech Fund to Accelerate Expansion

LONDON--(BUSINESS WIRE)--Intelligent Legal Solutions (ILS), the company behind the leading side letter management platform, ProVision, announced today a strategic investment from The LegalTech Fund (TLTF), a U.S. venture capital firm focused exclusively on companies transforming the world of law. Launched in 2024, ILS designs reliable, intuitive software that automates time-consuming legal tasks so lawyers can increase efficiency, improve quality, and focus on higher-value work. Its flagship pl...
-

SG Entertech Unveils Innovative Android VR Mini Platform ‘Snack VR’ and Seeks Expansion into Southeast Asia

SEOUL, South Korea--(BUSINESS WIRE)--South Korean VR start-up SG Entertech launches its Snack VR, an innovative VR mini-platform that overcomes the limits of traditional VR arcades....
-

Simu Liu Joins Elevate Festival 2025 Lineup as Agenda Goes Live

TORONTO--(BUSINESS WIRE)--Simu Liu - Canadian actor, advocate, and investor - will take the stage at Elevate Festival, Canada’s leading platform for startups, investors, and innovators, when it returns for its seventh year on October 7-9 in Toronto. Built on a foundation of entrepreneurship and innovation, Elevate has grown into the country’s national stage for technology, while keeping founders and the startup community at its core. In 2025, the festival will gather 10,000 attendees at a pivot...
-

Resumen: RevoAb™, un nuevo servicio para la ingeniería de desarrollo de anticuerpos

SENDAI, Japón--(BUSINESS WIRE)--RevolKa Ltd. (RevolKa), una empresa biotecnológica financiada con capital riesgo que ofrece una plataforma tecnológica puntera de ingeniería de proteínas basada en inteligencia artificial, llamada ai Protein® se complace en anunciar el lanzamiento de un nuevo servicio de investigación por contrato, RevoAb™. Este servicio diseña anticuerpos para mejorar las propiedades fisicoquímicas y proteger la afinidad de unión a los antígenos. Acerca de RevoAb™ Desde diciembr...
-

Samenvatting: 'RevoAb™', een nieuwe service voor engineering van de ontwikkelbaarheid van antilichamen

SENDAI, Japan--(BUSINESS WIRE)--RevolKa Ltd. (RevolKa), een biotechnologiebedrijf gesteund door risicokapitaal dat een baanbrekend technologieplatform aangestuurd door AI voor de ontwikkeling van eiwitten aanbiedt, ai Protein® genaamd, kondigt met genoegen de lancering van 'RevoAb™' aan, een nieuwe contractonderzoeksservice. Deze service ontwikkelt antilichamen om fysicochemische eigenschappen te verbeteren, terwijl het de antigeenbindingsaffiniteit beschermt. Over RevoAb™ Sinds december 2023 b...